Dow Up 1.31% Nasdaq Up 2.40%

Celgene Corporation (CELG)

-NasdaqGS
94.97 2.97(3.23%) Oct 21, 4:00PM EDT
Prev Close:92.00
Open:93.22
Bid:95.00 x 100
Ask:96.77 x 100
1y Target Est:104.48
Beta:1.5
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:93.22 - 95.90
52wk Range:66.85 - 96.50
Volume:9,990,097
Avg Vol (3m):4,519,210
Market Cap:75.93B
P/E (ttm):54.90
EPS (ttm):1.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGUp 3.23%75.93B
JNJ283.04B

Key Statistics

Forward P/E (1 yr):19.46
P/S (ttm):10.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.67
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback